METHYPRYLON - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for methyprylon and what is the scope of freedom to operate?
Methyprylon
is the generic ingredient in one branded drug marketed by Roche and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for METHYPRYLON
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 15 |
Patent Applications: | 2,524 |
DailyMed Link: | METHYPRYLON at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for METHYPRYLON
US Patents and Regulatory Information for METHYPRYLON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roche | NOLUDAR | methyprylon | ELIXIR;ORAL | 009660-007 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Roche | NOLUDAR | methyprylon | TABLET;ORAL | 009660-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Roche | NOLUDAR | methyprylon | CAPSULE;ORAL | 009660-008 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Roche | NOLUDAR | methyprylon | TABLET;ORAL | 009660-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |